Literature DB >> 18180794

Interferon type I responses in primary and secondary infections.

Mohammed Alsharifi1, Arno Müllbacher, Matthias Regner.   

Abstract

The mammalian host responds to a microbial infection with a rapid innate immune reaction that is dominated by type I interferon (IFN-I) release. Most cells of vertebrates can respond to microbial attack with IFN-I production, but the cell type responsible for most of the systemic IFN-I release is thought to be plasmacytoid dendritic cells (pDCs). Besides its anti-microbial and especially anti-viral properties IFN-I also exerts a regulatory role on many facets of the sequential adaptive immune response. One of these is being the recently described partial, systemic activation of the vast majority of B and T lymphocytes in mice, irrespective of antigen reactivity. The biological significance of this partial activation of lymphocytes is at present speculative. Secondary infections occurring within a short time span of a primary infection fail to elicit a similar lymphocyte activation response due to a refractory period in systemic IFN-I production. This period of exhaustion in IFN-I responses is associated with an increased susceptibility of the host to secondary infections. The latter correlates with well-established clinical observations of heightened susceptibility of patients to secondary microbial infections after viral episodes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180794     DOI: 10.1038/sj.icb.7100159

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  33 in total

1.  Activation of an antiviral response in normal but not transformed mouse cells: a new determinant of minute virus of mice oncotropism.

Authors:  Svitlana Grekova; Rainer Zawatzky; Rita Hörlein; Celina Cziepluch; Michal Mincberg; Claytus Davis; Jean Rommelaere; Laurent Daeffler
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

2.  IRF7-dependent type I interferon production induces lethal immune-mediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus.

Authors:  Wen Li; Markus J Hofer; So Ri Jung; Sue-Ling Lim; Iain L Campbell
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

3.  Activation of TLR3/interferon signaling pathway by bluetongue virus results in HIV inhibition in macrophages.

Authors:  Ming Dai; Xu Wang; Jie-Liang Li; Yu Zhou; Ming Sang; Jin-Biao Liu; Jian-Guo Wu; Wen-Zhe Ho
Journal:  FASEB J       Date:  2015-08-21       Impact factor: 5.191

4.  Toll-like receptor 3 signaling inhibits simian immunodeficiency virus replication in macrophages from rhesus macaques.

Authors:  Ming Sang; Jin-Biao Liu; Ming Dai; Jian-Guo Wu; Wen-Zhe Ho
Journal:  Antiviral Res       Date:  2014-10-23       Impact factor: 5.970

5.  The amino terminus of the vaccinia virus E3 protein is necessary to inhibit the interferon response.

Authors:  Stacy D White; Bertram L Jacobs
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

6.  Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus.

Authors:  Markus J Hofer; Wen Li; Peter Manders; Rachael Terry; Sue Ling Lim; Nicholas J C King; Iain L Campbell
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

Review 7.  Transgenic models for cytokine-induced neurological disease.

Authors:  Iain L Campbell; Markus J Hofer; Axel Pagenstecher
Journal:  Biochim Biophys Acta       Date:  2009-10-14

8.  Role of PKR and Type I IFNs in viral control during primary and secondary infection.

Authors:  Yumi Nakayama; Erin H Plisch; Jeremy Sullivan; Chester Thomas; Charles J Czuprynski; Bryan R G Williams; M Suresh
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

9.  The viral interferon regulatory factors of kaposi's sarcoma-associated herpesvirus differ in their inhibition of interferon activation mediated by toll-like receptor 3.

Authors:  Sarah R Jacobs; Sean M Gregory; John A West; Amy C Wollish; Christopher L Bennett; David J Blackbourn; Mark T Heise; Blossom Damania
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

10.  Type I interferons differentially modulate maternal host immunity to infection by Listeria monocytogenes and Salmonella enterica serovar Typhimurium during pregnancy.

Authors:  Gerard Agbayani; Kristina Wachholz; Shawn P Murphy; Subash Sad; Lakshmi Krishnan
Journal:  Am J Reprod Immunol       Date:  2018-12-04       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.